Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1991 1
1993 1
1994 1
2002 1
2003 1
2007 1
2010 1
2016 1
2017 2
2018 2
2019 2
2020 3
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Pathologic differential diagnosis of metastatic carcinoma in the liver.
Park JH, Kim JH. Park JH, et al. Clin Mol Hepatol. 2019 Mar;25(1):12-20. doi: 10.3350/cmh.2018.0067. Epub 2018 Oct 5. Clin Mol Hepatol. 2019. PMID: 30300991 Free PMC article. Review.
Representative carcinomas that frequently metastasize to the liver include colorectal carcinoma, breast carcinoma, neuroendocrine tumors, lung carcinoma, and gastric carcinoma. ...Although morphology is the most important feature for a pa …
Representative carcinomas that frequently metastasize to the liver include colorectal carcinoma, breast carcinoma, neuroend …
Neuroendocrine tumors of the gallbladder: an evaluation and reassessment of management strategy.
Eltawil KM, Gustafsson BI, Kidd M, Modlin IM. Eltawil KM, et al. J Clin Gastroenterol. 2010 Nov-Dec;44(10):687-95. doi: 10.1097/MCG.0b013e3181d7a6d4. J Clin Gastroenterol. 2010. PMID: 20375728 Review.
RESULTS: GB-NETs probably derive from either a multipotent stem cell or neuroendocrine cells in intestinal or gastric metaplasia of the gallbladder epithelium, which occurs consequent upon cholelithiasis/chronic inflammation. ...The 5 year survival rate for tumors c …
RESULTS: GB-NETs probably derive from either a multipotent stem cell or neuroendocrine cells in intestinal or gastric metaplas …
Medical treatment of gastrinomas.
Auernhammer CJ, Göke B. Auernhammer CJ, et al. Wien Klin Wochenschr. 2007;119(19-20):609-15. doi: 10.1007/s00508-007-0877-1. Wien Klin Wochenschr. 2007. PMID: 17985097 Review.
Further medical therapy is only recommended in cases of progressive metastatic gastrinoma. ...In poorly differentiated neuroendocrine carcinoma (G3) chemotherapy with etoposide plus cisplatin is possible. ...
Further medical therapy is only recommended in cases of progressive metastatic gastrinoma. ...In poorly differentiated neur …
Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement.
Coriat R, Walter T, Terris B, Couvelard A, Ruszniewski P. Coriat R, et al. Oncologist. 2016 Oct;21(10):1191-1199. doi: 10.1634/theoncologist.2015-0476. Epub 2016 Jul 8. Oncologist. 2016. PMID: 27401895 Free PMC article. Review.
The main localizations of NET G-3 are the pancreas, stomach, and colon. Treatment for NET G-3 is not standardized and is balanced between G-1/2 neuroendocrine tumor and neuroendocrine carcinoma treatments. ...The chemotherapy regimen in pancreatic NET …
The main localizations of NET G-3 are the pancreas, stomach, and colon. Treatment for NET G-3 is not standardized and is balanced bet …
Endocrinological Toxicity Secondary to Treatment of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs).
Alexandraki KI, Daskalakis K, Tsoli M, Grossman AB, Kaltsas GA. Alexandraki KI, et al. Trends Endocrinol Metab. 2020 Mar;31(3):239-255. doi: 10.1016/j.tem.2019.11.003. Epub 2019 Dec 12. Trends Endocrinol Metab. 2020. PMID: 31839442 Review.
Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are increasingly recognized, characterized by prolonged survival even with metastatic disease. ...
Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are increasingly recognized, characterized by prolonged survival even with …
Clinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas.
Liu DJ, Fu XL, Liu W, Zheng LY, Zhang JF, Huo YM, Li J, Hua R, Liu Q, Sun YW. Liu DJ, et al. World J Gastroenterol. 2017 Jan 21;23(3):516-524. doi: 10.3748/wjg.v23.i3.516. World J Gastroenterol. 2017. PMID: 28210088 Free PMC article.
AIM: To provide more information and therapeutic methods about gastric neuroendocrine carcinomas (G-NECs) which occur rarely but are highly malignant and clinically challenging. ...Survival was better in patients with tumor located in the cardiac region of th …
AIM: To provide more information and therapeutic methods about gastric neuroendocrine carcinomas (G-NECs) which occur r …
Characteristics and treatment results of patients with gastroenteropancreatic neuroendocrine tumors in a tertiary care centre.
Bazarbashi S, Aseafan M, Elgazzar T, Alkhayat M, Alghabban A, Abdelgawad MI, Alshamsan B, Alshibany A, Elhassan T, Aljubran A, Alzahrani A, Alhindi H, Raef H. Bazarbashi S, et al. BMC Endocr Disord. 2023 Apr 7;23(1):74. doi: 10.1186/s12902-023-01326-1. BMC Endocr Disord. 2023. PMID: 37029347 Free PMC article.
BACKGROUND: Gastroenteropancreatic Neuroendocrine tumors (GEP-NET) are rare neoplasms with limited reported data from the Middle East. ...Forty-one patients (57%) had well-differentiated grade (G)1, 21 (29%) had G2, and 4 (6%) had G3. In five patients, the pathology was …
BACKGROUND: Gastroenteropancreatic Neuroendocrine tumors (GEP-NET) are rare neoplasms with limited reported data from the Middle East …
ctDNA in Neuroendocrine Carcinoma of Gastroenteropancreatic Origin or of Unknown Primary: The CIRCAN-NEC Pilot Study.
Gerard L, Garcia J, Gauthier A, Lopez J, Durand A, Hervieu V, Lemelin A, Chardon L, Landel V, Gibert B, Lombard-Bohas C, Payen L, Walter T. Gerard L, et al. Neuroendocrinology. 2021;111(10):951-964. doi: 10.1159/000512502. Epub 2020 Oct 23. Neuroendocrinology. 2021. PMID: 33099543
INTRODUCTION: Gastroenteropancreatic neuroendocrine carcinomas (GEPNEC) are characterized by a heterogeneous molecular profile and a poor prognosis. ...
INTRODUCTION: Gastroenteropancreatic neuroendocrine carcinomas (GEPNEC) are characterized by a heterogeneous molecular profile and a …
High-specific-activity iodine 131 metaiodobenzylguanidine for the treatment of metastatic pheochromocytoma or paraganglioma: a novel therapy for an orphan disease.
Jimenez C, Núñez R, Wendt R. Jimenez C, et al. Curr Opin Endocrinol Diabetes Obes. 2020 Jun;27(3):162-169. doi: 10.1097/MED.0000000000000544. Curr Opin Endocrinol Diabetes Obes. 2020. PMID: 32250976 Review.
The definition of malignancy relies on the presence of metastasis. Metastatic pheochromocytomas and paragangliomas are usually advanced, incurable tumors with limited therapeutic options. ...This review reports the benefits and toxicity of HSA-I-131-MIBG, its physic …
The definition of malignancy relies on the presence of metastasis. Metastatic pheochromocytomas and paragangliomas are usually advanc …
Regional treatment of hepatic metastases and hepatocellular carcinoma.
Kemeny N, Schneider A. Kemeny N, et al. Curr Probl Cancer. 1989 Jul-Aug;13(4):197-283. doi: 10.1016/0147-0272(89)90007-x. Curr Probl Cancer. 1989. PMID: 2548812 Review.
We will discuss the systemic and regional therapy of colorectal, gastric, and gallbladder cancers. Breast carcinoma and malignant melanoma frequently metastasize to the liver, and we have described systemic and regional treatments of these diseases. ...The la …
We will discuss the systemic and regional therapy of colorectal, gastric, and gallbladder cancers. Breast carcinoma and …
17 results